Summary:
An open-label, multicenter study to assess the long-term safety of once-daily study medication in subjects with moderate to severe chronic nonmalignant and nonneuropathic pain.
Qualified Participants Must:
• Be at least 18 years of age
•
Have had their predominant pain condition for at least 3 months prior to screening
•
If pain is in low back, it must be above the knees
•
Be currently untreated for the pain condition OR on a stable treatment for the last 14 days
Qualified Participants May Receive:
All study-related exam, lab work and medications are provided free-of-charge. Compensation is available for time and travel-related expenses.